Fig. 3From: Circulating free plasma tumor DNA in patients with advanced gastric cancer receiving systemic chemotherapyIllustrative level of tDNA (ug/μL) in patient 1, patient 2 and patient 3 over time of treatment, related to progression disease (PD) time according the RECIST criteria 1.1.avaliation utilizing computadorized tomography (CT)Back to article page